TrkA immunostaining in breast tumours (Figure 2) was observed preferentially in myoepithelial and cancer epithelial cells of IDC (Figure 2A–F), ILC (Figure 2G–I) and DCIS (Figure 2J–K). The gene discussed is NTRK1; the disease is ductal breast carcinoma in situ.